Compare Shell PLC (SHEL) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Shell PLC vs Health Care Select Sector SPDR Fund — how do they compare? Shell PLC trades at $100.18 (market cap $284.34B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Shell PLC is far larger — about 6.5× Health Care Select Sector SPDR Fund's market cap, and Shell PLC pays a 3.12% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Shell PLC for 90 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| SHEL | XLV | |
|---|---|---|
Market Cap | $284.34B | $43.48B |
Volume | 9,097,469 | 11,121,431 |
Sector | Energy | — |
52-Week High | $100.20 | $175.68 |
52-Week Low | $70.31 | $141.95 |
Typical Hold Time | 90 Days | 100 Days |
Enterprise Value | $326.04B | — |
Dividend Yield | 3.12% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Shell (SHEL) trades at $100.2, up 3.46% today, approaching its 52-week high. The stock shows strong technical momentum with bullish moving averages and recent earnings beats in Q1 and Q2 2026. Fundamentally, the company maintains solid profitability with an 8.76% net margin and attractive valuation multiples, including a P/E of 11.08. Recent news highlights strategic expansions in LNG capacity and carbon capture projects, reinforcing long-term growth prospects.
The outlook for SHEL is positive, supported by analyst consensus favoring Buy ratings and a $102.53 price target. Key opportunities include LNG expansion and portfolio optimization, while risks involve energy price volatility and execution of large-scale projects. The stock presents a balanced risk-reward profile for investors seeking exposure to energy transition themes.
XLV trades at $168.16, down 0.39% with a bearish technical signal from moving averages. The healthcare ETF maintains strong cost advantages with a 0.08% expense ratio compared to peers. Recent news highlights XLV's defensive positioning during market volatility and its historical outperformance during Fed rate hikes. Technical indicators show RSI levels in neutral territory while ADX signals selling pressure.
XLV offers diversified healthcare exposure with competitive expense ratios, positioning it well for defensive investing. Key risks include political uncertainty around healthcare policy and concentrated exposure to domestic S&P 500 stocks. The ETF's low-cost structure and sector diversification provide stability amid market volatility, though technical indicators suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
